231 related articles for article (PubMed ID: 34522845)
1. The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders.
Eichinger S; Morange PE; Cattaneo M; Fretigny M; Rauch A; van Hylckama Vlieg A; Trégouët DA; Ruf W; Levi M; Páramo JA; van der Poll T; Kyrle PA; Garagiola I; Peyvandi F
Hemasphere; 2021 Oct; 5(10):e643. PubMed ID: 34522845
[No Abstract] [Full Text] [Related]
2. The EHA Research Roadmap: Transfusion Medicine.
Stanworth SJ; Brand A; Kaveri SV; Vrielink H; Greinacher A; Domanović D; von Lindern M; Allard S; Bayry J; Bohonek M; Buser A; Claas FHJ; Knutson F; Lozano M; Olsson ML; Pirenne F; Rebulla P; So-Osman C; Tissot JD; Toye AM; Ushiro-Lumb I; van den Akker E; Zeerleder S
Hemasphere; 2022 Feb; 6(2):e670. PubMed ID: 35098039
[No Abstract] [Full Text] [Related]
3. The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies.
Einsele H; Briones J; Ciceri F; García Cadenas I; Falkenburg F; Bolaños N; Heemskerk HMM; Houot R; Hudecek M; Locatelli F; Morgan K; Morris EC; O'Dwyer M; Sierra JG; van den Brink M; van de Loosdrecht AA
Hemasphere; 2021 Oct; 5(10):e642. PubMed ID: 34522844
[No Abstract] [Full Text] [Related]
4. The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Engert A; Balduini C; Brand A; Coiffier B; Cordonnier C; Döhner H; de Wit TD; Eichinger S; Fibbe W; Green T; de Haas F; Iolascon A; Jaffredo T; Rodeghiero F; Salles G; Schuringa JJ;
Haematologica; 2016 Feb; 101(2):115-208. PubMed ID: 26819058
[TBL] [Abstract][Full Text] [Related]
5. The European Hematology Association: strengthening hematology in Europe and beyond.
Foà R
Expert Rev Hematol; 2011 Apr; 4(2):133-6. PubMed ID: 21495922
[TBL] [Abstract][Full Text] [Related]
6. Proceedings from the 1st Insights in Hematology Symposium, Cluj-Napoca, Romania March 11-12, 2016.
Bojan A; Berindan-Neagoe I; Ciurea S; Dima D; Fuji S; Ghiaur G; Grewal R; Mccormack E; Tanase A; Trifa A; Tomuleasa C
Rom J Intern Med; 2016 Sep; 54(3):157-160. PubMed ID: 27658163
[TBL] [Abstract][Full Text] [Related]
7. Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Rejeski K; Subklewe M; Aljurf M; Bachy E; Balduzzi A; Barba P; Bruno B; Benjamin R; Carrabba MG; Chabannon C; Ciceri F; Corradini P; Delgado J; Di Blasi R; Greco R; Houot R; Iacoboni G; Jäger U; Kersten MJ; Mielke S; Nagler A; Onida F; Peric Z; Roddie C; Ruggeri A; Sánchez-Guijo F; Sánchez-Ortega I; Schneidawind D; Schubert ML; Snowden JA; Thieblemont C; Topp M; Zinzani PL; Gribben JG; Bonini C; Sureda A; Yakoub-Agha I
Blood; 2023 Sep; 142(10):865-877. PubMed ID: 37300386
[TBL] [Abstract][Full Text] [Related]
8. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).
Hayden PJ; Roddie C; Bader P; Basak GW; Bonig H; Bonini C; Chabannon C; Ciceri F; Corbacioglu S; Ellard R; Sanchez-Guijo F; Jäger U; Hildebrandt M; Hudecek M; Kersten MJ; Köhl U; Kuball J; Mielke S; Mohty M; Murray J; Nagler A; Rees J; Rioufol C; Saccardi R; Snowden JA; Styczynski J; Subklewe M; Thieblemont C; Topp M; Ispizua ÁU; Chen D; Vrhovac R; Gribben JG; Kröger N; Einsele H; Yakoub-Agha I
Ann Oncol; 2022 Mar; 33(3):259-275. PubMed ID: 34923107
[TBL] [Abstract][Full Text] [Related]
9. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in hematology: an update from the 16th Congress of the EHA.
O'Neill T
Expert Rev Hematol; 2011 Dec; 4(6):587-9. PubMed ID: 22077521
[TBL] [Abstract][Full Text] [Related]
11. EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update.
Iolascon A; De Franceschi L; Muckenthaler M; Taher A; Rees D; de Montalembert M; Rivella S; Eleftheriou A; Cappellini MD
Hemasphere; 2019 Jun; 3(3):e208. PubMed ID: 31723835
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. The EHA Research Roadmap: Infections in Hematology.
Cordonnier C; Ljungman P; Cesaro S; Hirsch HH; Maschmeyer G; von Lilienfeld-Toal M; Vehreschild M; Mikulska M; Emonts M; Gennery AR; Neofytos D; Bochud PY; Einsele H; Maertens J
Hemasphere; 2021 Dec; 5(12):e662. PubMed ID: 34877477
[No Abstract] [Full Text] [Related]
14. An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA.
Rejeski K; Greco R; Onida F; Sánchez-Ortega I; Bonini C; Sureda A; Gribben JG; Yakoub-Agha I; Subklewe M
Hemasphere; 2023 May; 7(5):e889. PubMed ID: 37125259
[TBL] [Abstract][Full Text] [Related]
15. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.
Spanjaart AM; Ljungman P; de La Camara R; Tridello G; Ortiz-Maldonado V; Urbano-Ispizua A; Barba P; Kwon M; Caballero D; Sesques P; Bachy E; Di Blasi R; Thieblemont C; Calkoen F; Mutsaers P; Maertens J; Giannoni L; Nicholson E; Collin M; Vaz CP; Metafuni E; Martinez-Lopez J; Dignan FL; Ribera JM; Nagler A; Folber F; Sanderson R; Bloor A; Ciceri F; Knelange N; Ayuk F; Kroger N; Kersten MJ; Mielke S
Leukemia; 2021 Dec; 35(12):3585-3588. PubMed ID: 34750508
[No Abstract] [Full Text] [Related]
16. Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting.
Li X; Zhang P; Sun H; Han L; Jiang Z; Yu J
Expert Opin Biol Ther; 2023; 23(12):1193-1195. PubMed ID: 37852928
[TBL] [Abstract][Full Text] [Related]
17. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract][Full Text] [Related]
18. Current and future commitment to hematology research.
Peterson CM; Harvath L
Hematol Oncol Clin North Am; 2004 Dec; 18(6):1215-34, vii. PubMed ID: 15511613
[TBL] [Abstract][Full Text] [Related]
19. Fifty-five years (1955-2010) of the Coagulation Section at Laboratory of Hematology, Sestre milosrdnice University Hospital, and its founder, hematologist Ljubomir Popović.
Stancić V; Stancić N; Vucelić V; Lang N; Grbac L
Acta Clin Croat; 2011 Sep; 50(3):385-94. PubMed ID: 22384775
[TBL] [Abstract][Full Text] [Related]
20. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Lyon AR; López-Fernández T; Couch LS; Asteggiano R; Aznar MC; Bergler-Klein J; Boriani G; Cardinale D; Cordoba R; Cosyns B; Cutter DJ; de Azambuja E; de Boer RA; Dent SF; Farmakis D; Gevaert SA; Gorog DA; Herrmann J; Lenihan D; Moslehi J; Moura B; Salinger SS; Stephens R; Suter TM; Szmit S; Tamargo J; Thavendiranathan P; Tocchetti CG; van der Meer P; van der Pal HJH;
Eur Heart J; 2022 Nov; 43(41):4229-4361. PubMed ID: 36017568
[No Abstract] [Full Text] [Related]
[Next] [New Search]
